Advances inbiomarkers for immune thrombocytopenia
10.13303/j.cjbt.issn.1004-549x.2021.06.028
- VernacularTitle:免疫性血小板减少症生物标志物的研究进展
- Author:
Fengyi ZHU
1
;
Nan CHE
1
;
Miaojia ZHANG
1
Author Information
1. Department of Rheumatology, the first affiliated hospital of Nanjing Medical University, Nanjing 210029, China
- Publication Type:Journal Article
- Keywords:
immune thrombocytopenia;
autoimmune disease;
biomarkers;
treatment response;
platelet count
- From:
Chinese Journal of Blood Transfusion
2021;34(6):665-668
- CountryChina
- Language:Chinese
-
Abstract:
Immune thrombocytopenia (ITP) is an autoimmune disease mediated by acquired immunity, with platelets decreased and hemorrhage being the primary clinical manifestations. The responses and platelet count levels after early treatment are important factors affecting long-term prognosis, however, current diagnostic methods and disease evaluation approaches are limited, and lack of specific biomarkers. In recent years, various biomolecules have been proposed as potential biomarkers for ITP. This paper reviews the value and advances in ITP-related biomarkers.
